Model | Genotype | Control | Diabetic patients | P-value |
Co-dominant | 5G/5G | 25 (50%) | 35 (50%) | 0.998 |
4G/5G | 22 (44%) | 31 (44.3%) | ||
4G/4G | 3 (6%) | 4 (5.7%) |